209 related articles for article (PubMed ID: 31468511)
21. Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases.
Kim Y; Hyun JW; Woodhall MR; Oh YM; Lee JE; Jung JY; Kim SY; Lee MY; Kim SH; Kim W; Irani SR; Waters P; Choi K; Kim HJ
Mult Scler Relat Disord; 2020 May; 40():101939. PubMed ID: 31978673
[TBL] [Abstract][Full Text] [Related]
22. Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated Diseases.
Avouac A; Maarouf A; Stellmann JP; Rico A; Boutiere C; Demortiere S; Marignier R; Pelletier J; Audoin B
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33722933
[TBL] [Abstract][Full Text] [Related]
23. E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Armangue T; Capobianco M; de Chalus A; Laetitia G; Deiva K;
Eur J Paediatr Neurol; 2020 Nov; 29():22-31. PubMed ID: 33191096
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.
Cobo-Calvo A; Sepúlveda M; Rollot F; Armangué T; Ruiz A; Maillart E; Papeix C; Audoin B; Zephir H; Biotti D; Ciron J; Durand-Dubief F; Collongues N; Ayrignac X; Labauge P; Thouvenot E; Bourre B; Montcuquet A; Cohen M; Deschamps R; Solà-Valls N; Llufriu S; De Seze J; Blanco Y; Vukusic S; Saiz A; Marignier R
J Neuroinflammation; 2019 Jul; 16(1):134. PubMed ID: 31266527
[TBL] [Abstract][Full Text] [Related]
25. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
[TBL] [Abstract][Full Text] [Related]
26. Clinical and MRI phenotype of children with MOG antibodies.
Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
[TBL] [Abstract][Full Text] [Related]
27. Rebound of relapses after discontinuation of rituximab in a patient with MOG-IgG1 positive highly relapsing optic neuritis: a case report.
Choi SJ; Kim B; Lee HJ; Kim SJ; Kim SM; Sung JJ
BMC Neurol; 2018 Dec; 18(1):216. PubMed ID: 30577778
[TBL] [Abstract][Full Text] [Related]
28. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
[TBL] [Abstract][Full Text] [Related]
29. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
López-Chiriboga AS; Majed M; Fryer J; Dubey D; McKeon A; Flanagan EP; Jitprapaikulsan J; Kothapalli N; Tillema JM; Chen J; Weinshenker B; Wingerchuk D; Sagen J; Gadoth A; Lennon VA; Keegan BM; Lucchinetti C; Pittock SJ
JAMA Neurol; 2018 Nov; 75(11):1355-1363. PubMed ID: 30014148
[TBL] [Abstract][Full Text] [Related]
30. Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies.
Nagashima M; Osaka H; Ikeda T; Matsumoto A; Miyauchi A; Kaneko K; Nakashima I; Nakano Y; Wakabayashi K; Monden Y; Yamagata T
Brain Dev; 2018 Aug; 40(7):607-611. PubMed ID: 29661590
[TBL] [Abstract][Full Text] [Related]
31. Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.
Salama S; Khan M; Levy M; Izbudak I
Mult Scler Relat Disord; 2019 Apr; 29():15-22. PubMed ID: 30658259
[TBL] [Abstract][Full Text] [Related]
32. Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.
Pedreño M; Sepúlveda M; Armangué T; Sabater L; Martínez-Hernandez E; Arrambide G; Blanco Y; Llufriu S; Martínez-Lapiscina EH; Mulero P; Sola-Valls N; Ruiz-García R; Tintoré M; Dalmau J; Graus F; Saiz A
Mult Scler Relat Disord; 2019 Feb; 28():230-234. PubMed ID: 30623863
[TBL] [Abstract][Full Text] [Related]
33. Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome.
Zhong X; Chang Y; Tan S; Wang J; Sun X; Wu A; Peng L; Lau AY; Kermode AG; Qiu W
BMC Neurol; 2019 May; 19(1):94. PubMed ID: 31072329
[TBL] [Abstract][Full Text] [Related]
34. Long-term efficacy of mycophenolate mofetil in myelin oligodendrocyte glycoprotein antibody-associated disorders: A prospective study.
Li S; Ren H; Xu Y; Xu T; Zhang Y; Yin H; Zhang W; Li J; Ren X; Fang F; Li W; Zhu Y; Peng B; Wang J; Zhong Y; Cui L
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32170045
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
[TBL] [Abstract][Full Text] [Related]
36. Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children.
Ramanathan S; O'grady GL; Malone S; Spooner CG; Brown DA; Gill D; Brilot F; Dale RC
Dev Med Child Neurol; 2019 May; 61(5):610-614. PubMed ID: 30221764
[TBL] [Abstract][Full Text] [Related]
37. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.
Cobo-Calvo A; Ruiz A; Maillart E; Audoin B; Zephir H; Bourre B; Ciron J; Collongues N; Brassat D; Cotton F; Papeix C; Durand-Dubief F; Laplaud D; Deschamps R; Cohen M; Biotti D; Ayrignac X; Tilikete C; Thouvenot E; Brochet B; Dulau C; Moreau T; Tourbah A; Lebranchu P; Michel L; Lebrun-Frenay C; Montcuquet A; Mathey G; Debouverie M; Pelletier J; Labauge P; Derache N; Coustans M; Rollot F; De Seze J; Vukusic S; Marignier R;
Neurology; 2018 May; 90(21):e1858-e1869. PubMed ID: 29695592
[TBL] [Abstract][Full Text] [Related]
38. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the effects of rituximab versus other immunotherapies for MOG-IgG-associated central nervous system demyelination: A meta-analysis.
Bai P; Zhang M; Yuan J; Zhu R; Li N
Mult Scler Relat Disord; 2021 Aug; 53():103044. PubMed ID: 34091176
[TBL] [Abstract][Full Text] [Related]
40. Encephalitis is an Important Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Diseases: A Single-Center Cohort Study.
Ren C; Zhou A; Zhou J; Zhuo X; Dai L; Tian X; Yang X; Gong S; Ding C; Fang F; Ren X; Zhang W
Pediatr Neurol; 2024 Mar; 152():98-106. PubMed ID: 38242024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
